Vaccinex, Inc.
Anti-CD100 antibodies and methods for using the same

Last updated:

Abstract:

Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.

Status:
Grant
Type:

Utility

Filling date:

28 Apr 2017

Issue date:

15 Mar 2022